AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound

AxoGen, Stock Of the Day, is flashing a buy signal. Ten out of 10 analysts are bullish about AxoGen after strong earnings and raised 2026 guidance.

Investors Business Daily • Jun 5, 2026

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

AxoGen NASDAQ: AXGN President and CEO Michael Dale said the company's growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected to be positive but have not yet been quantified.

MarketBeat • May 14, 2026

Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Seeking Alpha • May 13, 2026

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla.

GlobeNewsWire • Apr 30, 2026

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 28, 2026

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

GlobeNewsWire • Apr 28, 2026

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.

Zacks Investment Research • Apr 28, 2026

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Apr 21, 2026

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research • Apr 17, 2026

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

ALACHUA, Fla. and TAMPA, Fla.

GlobeNewsWire • Apr 14, 2026